Company Overview

Stemtech Corporation (OTCQB: STEK) is a U.S.-based nutraceutical and wellness company focused on dietary supplements, stem cell nutrition products, and wellness formulations marketed primarily through direct selling and network marketing channels. The company operates in the health and wellness industry, with product categories centered on botanical extracts, stem cell support supplements, skin care, and cannabinoid-related wellness offerings. Revenue has historically been generated through product sales distributed via independent sales representatives and international distributor networks.

The company was founded in 2005 and evolved from a niche stem cell nutrition business into a broader wellness and direct-sales enterprise. Stemtech has emphasized proprietary botanical formulations and consumer products positioned around supporting healthy stem cell physiology and overall wellness. Public filings and company disclosures indicate that the company has periodically restructured operations, expanded internationally, and explored adjacent wellness categories to diversify revenue streams and distributor engagement.

Business Operations

Stemtech conducts operations primarily through its direct selling infrastructure and wellness product distribution activities. Its core business units have included StemRelease3, StemFlo, and other dietary supplement lines, along with wellness and skin care offerings marketed through independent distributors. The company has also been associated with cannabinoid-related initiatives and product development efforts tied to wellness and consumer health markets. Revenue generation is primarily derived from product sales, distributor enrollments, and recurring customer purchases through its network marketing model.

The company’s operations have historically included activities in the United States as well as selected international markets in Asia, Latin America, and parts of Europe through distributor partnerships and regional sales organizations. Public disclosures reference relationships with international distribution networks and subsidiaries supporting localized operations. Data regarding the scale and financial contribution of individual international markets is limited in publicly available filings, and some operational details are inconclusive based on available public sources.

Strategic Position & Investments

Stemtech’s strategic direction has focused on expanding its wellness product portfolio, strengthening distributor recruitment and retention, and leveraging consumer demand for nutritional supplements and alternative wellness products. The company has emphasized formulations tied to stem cell nutrition concepts and has sought to differentiate itself through proprietary ingredient combinations and branded wellness products. Public filings indicate that management has periodically pursued restructuring initiatives intended to improve operational efficiency and stabilize revenue performance.

The company has also explored growth through acquisitions, licensing arrangements, and strategic partnerships within the health and wellness sector. Certain disclosures reference investments or initiatives related to cannabinoid wellness products and international expansion opportunities. However, detailed financial outcomes from these initiatives have not always been consistently disclosed across public filings, and some information regarding the long-term commercial impact of these investments remains inconclusive based on available public sources.

Geographic Footprint

Stemtech is headquartered in the United States, with corporate activities historically centered in Florida. The company has maintained international distribution operations through direct selling networks and regional partnerships across multiple global markets. Public disclosures indicate activity in regions including North America, South America, Asia-Pacific, and parts of Europe.

International operations have been important to the company’s growth strategy, particularly in emerging direct-selling markets where wellness and nutritional supplement demand has expanded. The company’s market presence outside the United States has relied significantly on distributor-based sales structures rather than large-scale owned manufacturing or retail infrastructure. The precise scale of regional operations varies over time and is not consistently detailed in all publicly available filings.

Leadership & Governance

Stemtech Corporation has historically been led by executives with backgrounds in direct selling, nutritional supplements, and wellness product commercialization. Leadership strategy has generally emphasized international expansion, distributor engagement, and development of proprietary wellness formulations. Public company governance has included oversight through executive management and a board of directors consistent with OTC-listed corporate structures.

Key executives identified in public filings and company disclosures include:

• Charles S. Arnold – Chairman and Chief Executive Officer
• John W. Meyer – Former Chief Financial Officer
• Ray C. Carter – Former executive leadership and operational roles
• Ricardo A. Mayoral – International leadership and business development roles

Executive roles and personnel have changed periodically over the company’s operating history. Certain leadership appointments and tenure periods vary across filings and announcements, and some historical executive information is inconclusive based on available public sources.